Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Intervalo de año de publicación
1.
J Biomed Mater Res B Appl Biomater ; 106(4): 1546-1557, 2018 05.
Artículo en Inglés | MEDLINE | ID: mdl-28755493

RESUMEN

The bone-induction capacity of a porous biphasic calcium phosphate (pBCP) using heterotopic implantation in mouse (mHI-model) and its efficacy as substitute for autograft in mandibular critical-size defect in rabbit (rabMCSD-model) was investigated. In mHI-model, pBCP was implanted into the thigh muscles and bone formation was histomorphometrically and immunohistochemically evaluated. In rabMCSD-model, 13 mm bone defects were treated with pBCP or autograft and bone repair comparatively evaluated by radiographic and histomorphometric methods. In mHI-model, formed bone and immunolabeling for bone morphogenetic protein-2 and osteopontin were observed in 90% of pBCP implanted samples after 12 weeks. In rabMCSD-model neither statistically significant difference was found in newly formed bone between pBCP and autograft groups at 4 weeks (18.8 ± 5.5% vs 27.1 ± 5.6%), 8 weeks (22.3 ± 2.7% vs 26.2 ± 5.1), and 12 weeks (19.6 ± 4.7% vs 19.6 ± 2.3%). At 12 weeks, the stability and contour of the mandible were restored in both treatments. Near tooth remaining, pBCP particles were covered by small amount of mineralized tissue exhibiting perpendicular attachments of collagen fiber bundles with histological characteristic of acellular cementum. Within the limitations of this study, it was concluded that pBCP is osteoinductive and able to stimulate the new formation of bone and cementum-like tissues in rabMCSD-model, suggesting that it may be an alternative to treatment of large bone defect and in periodontal regenerative therapy. © 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 106B: 1546-1557, 2018.


Asunto(s)
Sustitutos de Huesos , Cerámica , Hidroxiapatitas , Mandíbula , Traumatismos Mandibulares , Osteogénesis/efectos de los fármacos , Animales , Proteína Morfogenética Ósea 2/química , Proteína Morfogenética Ósea 2/farmacocinética , Proteína Morfogenética Ósea 2/farmacología , Sustitutos de Huesos/química , Sustitutos de Huesos/farmacocinética , Sustitutos de Huesos/farmacología , Trasplante Óseo , Cerámica/química , Cerámica/farmacocinética , Cerámica/farmacología , Modelos Animales de Enfermedad , Hidroxiapatitas/química , Hidroxiapatitas/farmacocinética , Hidroxiapatitas/farmacología , Masculino , Mandíbula/metabolismo , Mandíbula/patología , Traumatismos Mandibulares/metabolismo , Traumatismos Mandibulares/patología , Traumatismos Mandibulares/terapia , Ratones , Ratones Endogámicos BALB C , Conejos
2.
Haemophilia ; 20(3): 421-5, 2014 May.
Artículo en Inglés | MEDLINE | ID: mdl-24330418

RESUMEN

The penetration of beta energy of 153-samarium ((153) Sm) (0.8 MeV) is not only appropriate for synovectomy of median articulations but is possible to improve the radiobiological effect using increased activities. The aim of this study was to assess the effectiveness of 185 MBq and 740 MBq of 153-samarium hydroxyapatite ((153) Sm-HA) in knees of haemophilic patients. Thirty-one patients--36 knees, 30 males, were divided into two groups without coinjection of corticosteroid: A - 14 patients (17 knees) treated with intra-articular dose of 185 MBq of (153) Sm-HA, average age 23 years; B--17 patients (19 knees) with 740 MBq of (153) Sm-HA, average age 21.3 years. The evaluation before and after 1 year of synovectomy used the following criteria: reduction in the number of haemarthroses and use of the coagulation factor and improvement in articular motility. Adverse-effects occurrence was considered too. Early and late scintigraphic studies were performed after synoviorthesis and no joint immobilization was recommended. The reduction in haemarthrosis and use of coagulation factor were: group 1--31.3% and 25%; group 2--81.5% and 79% with P < 0.001 respectively; no significant improvement in knees motility was noted for both groups. Four cases of mild reactional synovitis were observed in each group. The scintigraphic control showed homogenous distribution of the radiopharmaceuticals with no articular escape; the material was considered safe by its permanence in the articulation. We have significant improvement in the synovectomy of haemophilic knees with 740 MBq of (153) Sm-HA; the less penetration of its beta radiation was compensated by the increased biological effect with the higher used activity.


Asunto(s)
Hemartrosis/radioterapia , Hemofilia A/complicaciones , Hidroxiapatitas/administración & dosificación , Radioisótopos/administración & dosificación , Samario/administración & dosificación , Sinovitis/etiología , Sinovitis/radioterapia , Adolescente , Niño , Relación Dosis-Respuesta en la Radiación , Femenino , Hemartrosis/etiología , Hemartrosis/metabolismo , Humanos , Hidroxiapatitas/farmacocinética , Inyecciones Intraarticulares , Articulación de la Rodilla/metabolismo , Articulación de la Rodilla/fisiopatología , Articulación de la Rodilla/efectos de la radiación , Masculino , Estudios Prospectivos , Samario/farmacocinética , Sinovitis/metabolismo , Resultado del Tratamiento , Adulto Joven
3.
Rev. odontol. Univ. Säo Paulo ; 8(4): 281-6, out.-dez. 1994. ilus
Artículo en Portugués | LILACS, BBO - Odontología | ID: lil-155760

RESUMEN

Foi realizada avaliaçäo histológica da resposta tecidual óssea frente à hidroxiapatita (HA) granular implantada em defeitos criados experimentalmente na mandíbula de ratos. Inicialmente, foi observada a presença de exsudato sero-fibrinoso, com grande quantidade de polimorfonucleares neutrófilos e, a seguir, ocorreu processo inflamatório crônico. Posteriormente, foram observadas células gigantes multinucleadas ao redor da imagem negativa dos cristais. Esse achado permaneceu até os períodos finais do experimento, configurando reaçäo do tipo corpo estranho, havendo também, nessa fase, atividade osteogênica ao redor do defeito ósseo


Asunto(s)
Ratas , Huesos/lesiones , Huesos/patología , Huesos/química , Hidroxiapatitas/efectos adversos , Hidroxiapatitas/uso terapéutico , Hidroxiapatitas/farmacocinética , Mandíbula/fisiopatología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA